No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Recent Uptick Might Appease Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Hedge Funds Owners After Losing 32% Over the Past Year
Breakeven Is Near for Fennec Pharmaceuticals Inc. (NASDAQ:FENC)
Fennec Pharmaceuticals Inc: MDA EN
Fennec Pharmaceuticals Inc: AUDITED ANNUAL FINANCIAL STATEMENTS EN
Fennec Pharmaceuticals | 10-K: FY2024 Annual Report
Maxim Group Maintains Fennec Pharmaceuticals(FENC.US) With Buy Rating, Maintains Target Price $15